Joel G Ray
Joel G Ray
St. Michael's Hospital
Verified email at
TitleCited byYear
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
WH Geerts, GF Pineo, JA Heit, D Bergqvist, MR Lassen, CW Colwell, ...
Chest 126 (3), 338S-400S, 2004
Prevention of venous thromboembolism
WH Geerts, JA Heit, GP Clagett, GF Pineo, CW Colwell, FA Anderson, ...
Chest 119 (1), 132S-175S, 2001
Maternal body mass index and the risk of preeclampsia: a systematic overview
TE O’Brien, JG Ray, WS Chan
Epidemiology 14 (3), 368-374, 2003
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
JG Ray, MJ Vermeulen, MJ Schull, DA Redelmeier
The Lancet 366 (9499), 1797-1803, 2005
Chronic dialysis and death among survivors of acute kidney injury requiring dialysis
R Wald, RR Quinn, J Luo, P Li, DC Scales, MM Mamdani, JG Ray, ...
Jama 302 (11), 1179-1185, 2009
Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta‐analysis
JG Ray, TE O'brien, WS Chan
Qjm 94 (8), 435-444, 2001
Folic acid and homocyst (e) ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review
JG Ray, CA Laskin
Placenta 20 (7), 519-529, 1999
Deep vein thrombosis and its prevention in critically ill adults
J Attia, JG Ray, DJ Cook, J Douketis, JS Ginsberg, WH Geerts
Archives of internal medicine 161 (10), 1268-1279, 2001
Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease
JG Ray
Archives of internal medicine 158 (19), 2101-2106, 1998
Association of neural tube defects and folic acid food fortification in Canada
JG Ray, C Meier, MJ Vermeulen, S Boss, PR Wyatt, DEC Cole
The Lancet 360 (9350), 2047-2048, 2002
Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation
JG Ray, WS Chan
Obstetrical & gynecological survey 54 (4), 265-271, 1999
Bias in published cost effectiveness studies: systematic review
CM Bell, DR Urbach, JG Ray, A Bayoumi, AB Rosen, D Greenberg, ...
Bmj 332 (7543), 699-703, 2006
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
G Saposnik, JG Ray, P Sheridan, M McQueen, E Lonn, ...
Stroke 40 (4), 1365-1372, 2009
Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT* study
JG Ray, MJ Vermeulen, JL Shapiro, AB Kenshole
Qjm 94 (7), 347-356, 2001
Use of statins and the subsequent development of deep vein thrombosis
JG Ray, M Mamdani, RT Tsuyuki, DR Anderson, EL Yeo, A Laupacis
Archives of internal medicine 161 (11), 1405-1410, 2001
Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence
WS Chan, J Ray, EK Wai, S Ginsburg, ME Hannah, PN Corey, ...
Archives of internal medicine 164 (7), 741-747, 2004
Brief overview of maternal triglycerides as a risk factor for pre‐eclampsia
JG Ray, P Diamond, G Singh, CM Bell
BJOG: An International Journal of Obstetrics & Gynaecology 113 (4), 379-386, 2006
Association between MRI exposure during pregnancy and fetal and childhood outcomes
JG Ray, MJ Vermeulen, A Bharatha, WJ Montanera, AL Park
Jama 316 (9), 952-961, 2016
Estimating the prevalence of renal insufficiency in seniors requiring long-term care
AX Garg, A Papaioannou, N Ferko, G Campbell, JA Clarke, JG Ray
Kidney international 65 (2), 649-653, 2004
Statin use and survival outcomes in elderly patients with heart failure
JG Ray, Y Gong, K Sykora, JV Tu
Archives of internal medicine 165 (1), 62-67, 2005
The system can't perform the operation now. Try again later.
Articles 1–20